Cargando…
Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma
Autores principales: | BATINAC, Tanja, HLAČA, Nika, SIMETIĆ, Luka, VALKOVIĆ, Frane, PETERNEL, Sandra, PRPIĆ-MASSARI, Larisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558335/ https://www.ncbi.nlm.nih.gov/pubmed/35146529 http://dx.doi.org/10.2340/actadv.v102.1433 |
Ejemplares similares
-
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
por: Shaikh, Saba S., et al.
Publicado: (2022) -
Current Concepts of Vitiligo Immunopathogenesis
por: Hlača, Nika, et al.
Publicado: (2022) -
Comprehensive Insight into Lichen Planus Immunopathogenesis
por: Vičić, Marijana, et al.
Publicado: (2023) -
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023) -
Cobimetinib- and vemurafenib-induced granulomatous dermatitis and
erythema induratum: A case report
por: Iafolla, Marco AJ, et al.
Publicado: (2019)